vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and DeFi Development Corp. (DFDV). Click either name above to swap in a different company.

Baird Medical Investment Holdings Ltd is the larger business by last-quarter revenue ($8.0M vs $4.6M, roughly 1.7× DeFi Development Corp.). DeFi Development Corp. runs the higher net margin — 1211.4% vs -142.7%, a 1354.1% gap on every dollar of revenue.

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

Automotive Design and Development Ltd (ADD) was an English company responsible for the creation of the futuristic-looking Nova kit car. It was based in Southampton from 1971 to 1973 after which it moved to Accrington, Lancashire until 1975. ADD failed and the rights to the Nova were bought by Nova Cars in Mirfield, West Yorkshire in 1978, which continued until 1990. A low volume production run was made by Nova Developments in Cornwall in the 1990s and the company was sold to India-based Aerot...

BDMD vs DFDV — Head-to-Head

Bigger by revenue
BDMD
BDMD
1.7× larger
BDMD
$8.0M
$4.6M
DFDV
Higher net margin
DFDV
DFDV
1354.1% more per $
DFDV
1211.4%
-142.7%
BDMD

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
BDMD
BDMD
DFDV
DFDV
Revenue
$8.0M
$4.6M
Net Profit
$-11.4M
$56.0M
Gross Margin
82.1%
98.1%
Operating Margin
-131.3%
Net Margin
-142.7%
1211.4%
Revenue YoY
647.2%
Net Profit YoY
11995.1%
EPS (diluted)
$1.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
DFDV
DFDV
Q3 25
$4.6M
Q2 25
$8.0M
$2.0M
Q1 25
$287.2K
Q4 24
$628.9K
Q3 24
$619.0K
Q2 24
$441.0K
Q1 24
$411.1K
Q3 23
$583.8K
Net Profit
BDMD
BDMD
DFDV
DFDV
Q3 25
$56.0M
Q2 25
$-11.4M
$15.4M
Q1 25
$-778.0K
Q4 24
$-487.0K
Q3 24
$-471.0K
Q2 24
$-805.0K
Q1 24
$-964.0K
Q3 23
$-1.6M
Gross Margin
BDMD
BDMD
DFDV
DFDV
Q3 25
98.1%
Q2 25
82.1%
98.6%
Q1 25
Q4 24
98.8%
Q3 24
98.7%
Q2 24
98.2%
Q1 24
97.9%
Q3 23
100.0%
Operating Margin
BDMD
BDMD
DFDV
DFDV
Q3 25
Q2 25
-131.3%
Q1 25
-307.5%
Q4 24
-107.9%
Q3 24
-73.3%
Q2 24
-193.2%
Q1 24
-247.7%
Q3 23
-280.7%
Net Margin
BDMD
BDMD
DFDV
DFDV
Q3 25
1211.4%
Q2 25
-142.7%
777.0%
Q1 25
-270.9%
Q4 24
-77.4%
Q3 24
-76.1%
Q2 24
-182.5%
Q1 24
-234.5%
Q3 23
-270.4%
EPS (diluted)
BDMD
BDMD
DFDV
DFDV
Q3 25
$1.95
Q2 25
$0.84
Q1 25
$-0.55
Q4 24
$0.55
Q3 24
$-0.05
Q2 24
$-0.08
Q1 24
$-0.70
Q3 23
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
DFDV
DFDV
Cash + ST InvestmentsLiquidity on hand
$1.4M
Total DebtLower is stronger
$8.4M
$131.4M
Stockholders' EquityBook value
$35.6M
$243.8M
Total Assets
$77.0M
$480.0M
Debt / EquityLower = less leverage
0.24×
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
DFDV
DFDV
Q3 25
$1.4M
Q2 25
$595.0K
Q1 25
$2.2M
Q4 24
$2.8M
Q3 24
$2.8M
Q2 24
$3.2M
Q1 24
$3.9M
Q3 23
$5.8M
Total Debt
BDMD
BDMD
DFDV
DFDV
Q3 25
$131.4M
Q2 25
$8.4M
$21.2M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Q3 23
Stockholders' Equity
BDMD
BDMD
DFDV
DFDV
Q3 25
$243.8M
Q2 25
$35.6M
$79.6M
Q1 25
$2.8M
Q4 24
$3.5M
Q3 24
$4.0M
Q2 24
$4.3M
Q1 24
$5.0M
Q3 23
$6.0M
Total Assets
BDMD
BDMD
DFDV
DFDV
Q3 25
$480.0M
Q2 25
$77.0M
$107.2M
Q1 25
$4.2M
Q4 24
$4.4M
Q3 24
$4.5M
Q2 24
$4.8M
Q1 24
$5.5M
Q3 23
$6.2M
Debt / Equity
BDMD
BDMD
DFDV
DFDV
Q3 25
0.54×
Q2 25
0.24×
0.27×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24
Q3 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
DFDV
DFDV
Operating Cash FlowLast quarter
$-3.2M
$-5.0M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-40.7%
Capex IntensityCapex / Revenue
0.6%
0.0%
Cash ConversionOCF / Net Profit
-0.09×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
DFDV
DFDV
Q3 25
$-5.0M
Q2 25
$-3.2M
$-1.3M
Q1 25
$-785.6K
Q4 24
$-2.4M
Q3 24
$-412.0K
Q2 24
$-680.8K
Q1 24
$-1.1M
Q3 23
$-586.2K
Free Cash Flow
BDMD
BDMD
DFDV
DFDV
Q3 25
Q2 25
$-3.2M
Q1 25
Q4 24
$-2.4M
Q3 24
Q2 24
$-687.4K
Q1 24
$-1.2M
Q3 23
$-595.3K
FCF Margin
BDMD
BDMD
DFDV
DFDV
Q3 25
Q2 25
-40.7%
Q1 25
Q4 24
-388.2%
Q3 24
Q2 24
-155.9%
Q1 24
-280.3%
Q3 23
-102.0%
Capex Intensity
BDMD
BDMD
DFDV
DFDV
Q3 25
0.0%
Q2 25
0.6%
Q1 25
Q4 24
3.7%
Q3 24
0.0%
Q2 24
1.5%
Q1 24
1.6%
Q3 23
1.6%
Cash Conversion
BDMD
BDMD
DFDV
DFDV
Q3 25
-0.09×
Q2 25
-0.08×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDMD
BDMD

Segment breakdown not available.

DFDV
DFDV

Digital Asset Treasury$3.8M82%
Other$831.0K18%

Related Comparisons